Two Sigma Investments’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Two Sigma Investments’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-142,900	Closed	-$572K	–	4131
2019 Q4	$572K	Sell	142,900 -89,977	-39%	-$423K	﹤0.01%	2692
2019 Q3	$1.14M	Buy	232,877 +38,174	+20%	+$214K	﹤0.01%	1868
2019 Q2	$1.19M	Buy	194,703 +3,354	+2%	+$17.8K	﹤0.01%	1811
2019 Q1	$1.11M	Buy	+191,349	New	+$1.98M	﹤0.01%	1756
2017 Q1	–	Sell	-122,762	Closed	-$1.55M	–	3496
2016 Q4	$1.55M	Buy	+122,762	New	+$2.29M	0.01%	1688
2015 Q1	–	Sell	-14,060	Closed	-$385K	–	2967
2014 Q4	$385K	Buy	+14,060	New	+$341K	﹤0.01%	1834

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Two Sigma Investments's DPLO Position: Q1 2020 in Review

Two Sigma Investments sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 142,900 shares — an estimated $572K sold.

Two Sigma Investments first reported a position in DPLO in Q4 2014 and held it in 6 quarters. The position peaked at $1.55M in Q4 2016. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

Two Sigma Investments reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
Two Sigma Investments sold 142,900 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $572K.
Two Sigma Investments first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 6 quarters.
Two Sigma Investments's DIPLOMAT PHARMACY, INC. position peaked at $1.55M in Q4 2016.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Two Sigma Investments's 13F filing for Q1 2020, filed 15 May 2020.